BMSSC
MDGL icon

B. Metzler seel. Sohn & Co’s Madrigal Pharmaceuticals MDGL Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$656K Hold
1,221
– – 0.01% 633
2026
Q1 		$639K Hold
1,221
– – 0.01% 606
2025
Q4 		$711K Hold
1,221
– – 0.01% 598
2025
Q3 		$560K Buy
+1,221
New +$456K ﹤0.01% 637

Other funds holding MDGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

B. Metzler seel. Sohn & Co's MDGL Position: Q2 2026 in Review

B. Metzler seel. Sohn & Co held its Madrigal Pharmaceuticals (MDGL) position steady in Q2 2026 at 1,221 shares worth $656K. The position accounts for 0.01% of the portfolio, ranked #633.

B. Metzler seel. Sohn & Co first reported a position in MDGL in Q3 2025 and has held it in 4 quarters since. The position peaked at $711K in Q4 2025. 197 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • B. Metzler seel. Sohn & Co held 1,221 shares of Madrigal Pharmaceuticals worth $656K as of Q2 2026.
  • B. Metzler seel. Sohn & Co left its Madrigal Pharmaceuticals share count unchanged in Q2 2026.
  • Madrigal Pharmaceuticals made up 0.01% of B. Metzler seel. Sohn & Co's portfolio in Q2 2026, its #633 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Madrigal Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • B. Metzler seel. Sohn & Co's Madrigal Pharmaceuticals position peaked at $711K in Q4 2025.
  • 197 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2026, filed 11 Aug 2026.